Patterson - UTI Energy: A Vastly Undervalued Energy Services Firm

The expanding opportunities that are becoming available in the United States in gas and oil shale will eventually lead to expanding opportunities in the oil services industry. One company that should benefit greatly is Patterson – UTI Energy (NASDAQ:PTEN).

“Patterson-UTI Energy, Inc., through it subsidiaries, provides onshore contract drilling services to oil and natural gas operators. The company offers pressure pumping services that consist of well stimulation and cementing for completion of new wells and remedial work on existing wells in Texas and the Appalachian Basin; and contract drilling services primarily in Texas, New Mexico, Oklahoma, Arkansas, Louisiana, Mississippi, Colorado, Utah, Wyoming, Montana, North Dakota, Pennsylvania, West Virginia, and western Canada”. (Business Description from Yahoo Finance)

8 reasons PTEN is a good value at $18 a share

PTEN is selling in the bottom half of its five-year valuation range based on P/E, P/B and P/CF.

The company has beat earnings estimates each of the last six quarters. The average beat over consensus over the previous four quarters has been 10%

It has the largest fleet is the fast growing Permian Basin.

PTEN has rapidly increasing earnings. It earned 72 cents in 2010, is expected to earn $2.23 a share in 2011 and $2.86 in 2012.

Revenue is expected to increase 75% in 2011 and 25% in 2012.

Earnings estimates for 2011 and 2012 have increased over the past three months

Its forward PE is 6.4, which is a 70% discount to its five-year average.

The stock price is way under analysts’ price targets. S&P has a $30 price target on PTEN, Credit Suisse is at $42 and the median analysts’ target is $34.

Disclosure: I have no positions in any stocks mentioned, but may initiate a long position in PTEN over the next 72 hours.

The Biotech Letter delivers unbiased research on stocks in one of the hottest sectors in today’s market. With my tested and proven Biotech Risk/Reward Maximizer System I’ve pulled in double and triple digit winners while carefully minimizing risk to weed out the losers. Each month you’ll receive research on profitable stocks with The Biotech Investor, a new advisory service focused on actionable, in-depth stock research on today’s hottest biotech stocks.

We only use your contact details to reply to your request for more information.We do not sell the personal contact data you submit to anyone else.

Thank you for your interest in Seeking Alpha PROWe look forward to contacting you shortly for a conversation.

Thank you for your interest in Seeking Alpha PRO

Our PRO subscription service was created for fund managers, and the cost of the product is
prohibitive for most individual investors.
PRO Alerts is our flagship product for individual investors who want to be faster
and smarter about their stocks. To learn more about it, click here.
If you are an investment professional with over $1M AUM and received this message
in error, click here and you will be contacted shortly.

Thank you for your interest in Seeking Alpha PROWe look forward to contacting you when we have an individual investor product ready!